OBJECTIVE - To describe glycemic control and identify correlates of elevate
d HbA(1c) levels in diabetic American Indians participating in the Strong H
eart Study which is a longitudinal study of cardiovascular disease in Ameri
can Indians in Arizona, Oklahoma, South Dakota, and North Dakota.
RESEARCH DESIGN AND METHODS - This analysis sis is based on data from the b
aseline (1989-1992) and first follow-up (1994 similar to 1995) examinations
of the Strong Heart Study. The 1,581 diabetic participants included in thi
s analysis were aged 45-74 years at baseline, were diagnosed with diabetes
before and at baseline, and had their HbA1(c),levels measured at followup.
HbA(1c) was used as the index of glycemic control. Characteristics that may
affect glycemic control were evaluated for cross-sectional and longitudina
l relationships by analysis of covariance and multiple regression.
RESULTS - There was no significant difference between median HbA(1c) at bas
eline (8.4%) and at follow-up (8.5%). Sex, age (inversely), and insulin and
oral hypoglycemic agent therapy were significantly related to HbA(1c), lev
els in both the cross-sectional and longitudinal analyses. Current smoking,
prior use of alcohol, and duration of diabetes were significant only for t
he cross-sectional data. Baseline HbA(1c) significantly and positively pred
icted HbA(1c) levels at follow-up. Comparison of HbA(1c) by therapy type sh
ows that insulin therapy produced a significant decrease in HbA(1c) between
the baseline and follow-up examinations.
CONCLUSIONS - Glycemic control was poor among diabetic American Indians par
ticipating in the Strong Heart Study Women, patients taking insulin or oral
hypoglycemic agents, and younger individuals had the worst control of all
the participants. Baseline HbA(1c), and weight loss predicted worsening of
control, whereas insulin therapy predicted improvement in control. Addition
al therapies and/or approaches are needed to improve glycemic control in th
is population.